by Waylon Wright | Oct 10, 2019
Pearl Pathways announces the hiring of Emily Baumann as a Clinical Research Analyst. Emily brings over four years of experience in global clinical trial project management and medical affairs to the Pearl Pathways Clinical Services team.Emily’s expertise...
by Waylon Wright | Sep 20, 2019
Session Title: Don’t Blow Your Big Chance: How to Win with FDA and EMA RegulatorsRobert Seevers, Senior Advisor at Pearl Pathways, will speak during this session and participate in the panel discussion as an expert on the topic. Session synopsis: The session will...
by Waylon Wright | Sep 20, 2019
Session Title: The Trials and Tribulations of Handling Legacy Products from a GMP and Regulatory PerspectiveJohn Lockwood, Director of RA/QA Services, will serve as the session leader and Mark Slisz, Senior Advisor, will speak as one of the subject matter experts for...
by Waylon Wright | Sep 16, 2019
Join us at the 2019 RAPS Regulatory Convergence conference in Philadelphia, PA from September 21 – 24, 2019. The annual RAPS Regulatory Convergence conference focuses exclusively on regulatory topics impacting the life science and healthcare industries....
by Waylon Wright | May 22, 2019
The International Council for Harmonization (ICH) released an updated version of its guideline on general considerations for clinical trials, RAPS reports. ICH released the guideline, E8(R1), earlier this May for public consultation on the draft.The revised guideline...